Fosinopril (Na)
Fosinopril (Na) is ACE inhibitor. It prevents the conversion of certain enzymes in the body. It prevents constriction of blood vessels and lower the blood pressure and makes the heart beat stronger. Fosinopril (Na) is used to treat hypertension (high blood pressure) and heart failure.
Primary Characteristics
It is of Synthetic origin and belongs to Proline.
It belongs to Angiotensin converting enzyme inhibitor-ACEI pharmacological group on the basis of mechanism of action and also classified in Antihypertensive Agents pharmacological group.
Molecular Weight: 585.6 · Solubility in Water: soluble · Solubility in Alcohol: soluble · Non-proprietary name: Fosinopril (Na).

Pharmacokinetics
Absorption: Fosinopril (Na) has an oral bioavailability is 18% (±18%).
Distribution: Fosinopril (Na) has a plasma protein binding is < 90%.
Elimination: it is metabolised via Intestinal, Hepatic, plasma half-life is 12 hr, renal excretion is 50%.
Advertisement
Indications
Fosinopril (Na) is primarily indicated in conditions like Cardiac failure, Congestive heart failure (adjunct), Gastric acid reduction during anaesthesia, Hypertension.
Contraindications
None recorded.
Dosage
Fosinopril (Na)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 25 mg | 25 mg | Every 24h | PO | |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | — | Not Recommended in this Age Group |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Fosinopril (Na) in overdosage may give rise to further complications which include Viral infections .
Fosinopril (Na) is known to cause more or less tolerable side effects which are usually transient. These include Chest pain, Diarrhea, Edema, Fatigue, Headache, Myalgia, Nausea, Paresthesias, Pharyngitis, Vomiting .
Warnings / Precautions
Available Brands
Click on a strength to view available brands.
Single Ingredient
Storage Conditions
Drug Classification
- 1.12.3.3 — ACE inhibitors